SAVA vs XRAY · $115.0M cap vs rev $1.78B
Cassava Sciences Inc (SAVA) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Cassava Sciences Inc (SAVA) is a biotechnology company listed on NASDAQ.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
SAVA does not have a complete income-statement cache yet.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
SAVA currently screens at market cap $115.0M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the SAVA and XRAY stock pages for the full models.
Not investment advice.